Hello, welcome toPeanut Shell B2B Foreign Trade Network_Professional B2B E-commerce Platform_Free B2B Information Publishing Network!
18951535724
title The qi fong nasion palace
Main products Nasal inflammation palace
investment cost 560,000
Business model Freedom chain, other
region GuangdongShenzhen
Leave a message 暂无
Hits 602
Update time 2026-07-24 10:42
expiration time
Franchise Details

The queen's nasal inflammation house is a brand for the treatment of nasal inflammation and has had clinical effects for 10 years. Consumers and investors alike have a good assessment of it, and the eu provides investors with complete information on the quest nasion house, including union fees, unionization processes, etc。

Shenzhen city's kee fong biotechnic company, inc., was registered in 2016. The company's predecessor, based on the ancestral secret formula, and the clinical effects of the physical clinic have been well received for more than 10 years, after which he invested heavily in improving the research and development product, "chi fong fong gyon" (chi fong gin) and "chi fong gin" (chi fong kung gin). It is the leader of top-of-the-art medical and technological products in the nostril care market, advocating "green therapy" for chinese medicine, no needles, no drugs, no surgery, the introduction of current international bioactive pharmaceutical technology, and breaking bottlenecks such as incurable nasal inflammation and repeated outbreaks. The plasters, the stings, the massages of the nasal cavity, the effective absorption of the fungus, the activation and repair of the storoids of nasal disease have brought evangelization to a large number of patients。

We're going to pay for the chi fong nasion palace

It costs a minimum of 400,000 and a maximum of 550,000, depending on the size of the store

The queen's nasal inflammation center has a profit analysis

The queen's nasal inflammation center is expected to open from $47,000 to $62,000 a month, depending on the circumstances

>Related Comments
No comments yet, be the first to comment
Contact Us

You are not logged in, please log in to view contact information


>Investment